Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
- 1 August 1997
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 72 (8) , 737-747
- https://doi.org/10.1016/s0025-6196(11)63594-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic networkClinical and Experimental Immunology, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Anti-neutrophil Cytoplasmic Antibodies and Disease Activity During Long-Term Follow-up of 70 Patients with Systemic VasculitisNephrology Dialysis Transplantation, 1991
- Infectious complications of cyclophosphamide treatment for vasculitisArthritis & Rheumatism, 1989
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979